Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline Transcript
Operator Welcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I will be your operator for today’s call. [Operator Instructions] Please note that